|
|
|
|
|
by klmr
3127 days ago
|
|
> Medical research has advanced a lot with the invention of CRISPR. You are overestimating the importance of CRISPR. Don’t get me wrong — it is hugely important and innovative. But it’s not even the most important biomedical research innovation of recent years (I’d give that title to RNA-seq or more generally next-gen sequencing technology; but there are several contenders). But at any rate all the innovations you list are — at least partly — driven by fundamental research in the public sector, not private companies. |
|
NGS on the other side is more or less a gradual development. While the exact technology may be novel or unique the whole process is not as can be seen by the various competing technologies that existed and still do exist within about 1 or 2 orders of magnitude in pricing over time. And gene expression read-out especially is not that novel at all given arrays existed for some time. Sure, the single applications are cool but quite a few could be done with related technologies.
But sure, in the end its not whether one thing matters more than the another as all together make a great progress.